JNK is phosphorylated in lung adenocarcinoma cells, hepatocellular carcinoma, colorectal cancer and pancreatic cancer, where it contributes to the progression of malignant cells and metastases [57,58,59,60,61]. Here, MAPK8 is linked to hepatocellular carcinoma.